LifeScience Biologics
CJ CheilJedang, ADM Form Amino Acid JV to Strengthen Supply in Americas
Proposed joint venture will manufacture and market amino acids critical to the livestock industry, supporting U.S. production, strengthening the global...
October 05, 2026 | News
Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies
Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...
October 05, 2026 | News
Novartis Signs $7.8B RNA Therapeutics Deal With Abogen Biosciences
Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager Agreement also gives Novartis exclusive options to license other...
October 05, 2026 | News
Ractigen Reports First Human Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy
First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in hu...
October 05, 2026 | News
Sartorius and MAbSilico Unite AI and Cell Line Development to Accelerate Biologics Discovery
Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line development The integrate...
October 02, 2026 | News
Rznomics Secures Positive EMA Opinion for Orphan Designation of RZ-001 in Glioma
Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the European Medicines Agency's (EMA...
October 02, 2026 | News
Piramal and NP2 Advance Generic Cancer Drug Cyclophosphamide Towards US Manufacturing
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturi...
October 02, 2026 | News
Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of Bispecific ADC TJ102
Phrontline Biopharma, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), announced that the first patient h...
October 02, 2026 | News
Health In Tech Launches AI-Powered HitRix Platform for Large-Group Health Insurance
AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby ...
October 02, 2026 | News
Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada
Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment throug...
October 01, 2026 | Analysis
Lilly’s Retatrutide Delivers 20.8% Weight Loss in Phase III Obesity and Type 2 Diabetes Trial
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over 80 weeks, with more than half...
October 01, 2026 | News
China Approves Jaypirca Across All Lines of Therapy for CLL/SLL
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...
September 30, 2026 | News
Link Cell Therapies Begins Phase I Trial of Logic-Gated CAR-T Therapy for Kidney Cancer
LNK001, an AND-gated CAR-T therapy targeting CAIX and ENPP3, is being evaluated in a Phase 1 study in advanced clear cell renal cell carcinoma at MD ...
September 30, 2026 | News
Hengrui Pharma Inks $2.6B Licensing Deal With Novo Nordisk for Oral GLP-1/GIP Therapy
HRS-1596 is a phase I-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total pot...
September 30, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
